Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Clinical Data has announced that its Cogenics division, a provider of genomics services, has partnered with SinoGenoMax Co, a genomics based biotechnology company, to provide high quality clinical genotyping services in China.
Subscribe to our email newsletter
Michael Lutz, global manager of Cogenics, said: “Our partnership with SinoGenoMax provides us with an established presence in China and an experienced international service partner who operates with similar platforms and high quality standards, thus expanding Cogenics’s offering to our growing global pharmaceutical customer base.”
Danny Ching, CEO of SinoGenoMax, said: “This strategic agreement between Cogenics and SinoGenoMax increases the genotyping services and geographical scope of both companies. SinoGenoMax provides genomics-based services to both domestic and international pharmaceutical companies and this partnership represents a significant opportunity for SinoGenoMax to widen its international spectrum.”